Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Recent clinical trials have shown that while bivalirudin exhibits similar efficacy with heparin, it offers several advantages over heparin, such as a better safety profile. We aimed to evaluate the efficacy and safety of bivalirudin use during Percutaneous Coronary Intervention (PCI) in the treatmen...

Full description

Bibliographic Details
Main Authors:	Abdul Hafeez Ahmad Hamdi, Ahmad Fauzi Dali, Thimarul Huda Mat Nuri, Muhammad Syafiq Saleh, Noor Nabila Ajmi, Chin Fen Neoh, Long Chiau Ming, Amir Heberd Abdullah, Tahir Mehmood Khan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-07-01
Series:	Frontiers in Pharmacology
Subjects:	acute coronary syndrome ischemic events myocardial infarction stroke glycoprotein IIb/IIIa inhibitor major bleeding
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00410/full

Similar Items

One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Jiawen Li, et al.
Published: (2023-07-01)

Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
by: Muhammad Shabbir Rawala, et al.
Published: (2020-03-01)

Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction
by: Bastiaan Zwart, et al.
Published: (2020-02-01)

Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression
by: Carolina Saleiro, et al.
Published: (2020-11-01)

Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Glycoprotein IIb/IIIa inhibitors and Unfractionated Heparin Monotherapy for patients undergoing percutaneous coronary intervention – A single centre observational study
by: Upendra Kaul, et al.
Published: (2015-07-01)

Ex vivo STUDY OF THE ACTION OF INTEGRIN RECEPTORS ANTAGONIST FROM ECHIS MULTISQUAMATIS SNAKE VENOM ON PLATELETS OF PREGNANT WOMEN WITH COMPICATIONS DURING GESTATION
by: O. M. PLATONOV, et al.
Published: (2023-04-01)

Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases
by: Salma Abdeladim, et al.
Published: (2021-01-01)

Arteriosclerosis and the promise of GPIIb/IIIa inhibitors in stroke Arteriosclerosis y nuevas perspectivas de los inhibidores del receptor GPIIb/IIIa en stroke
by: GUSTAVO SAPOSNIK, et al.
Published: (2000-03-01)

Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trials
by: Vincent Roule, et al.
Published: (2017-02-01)

In Vitro Antiplatelet Activity of Mulberroside C through the Up-Regulation of Cyclic Nucleotide Signaling Pathways and Down-Regulation of Phosphoproteins
by: Hyuk-Woo Kwon, et al.
Published: (2021-06-01)

Scorpion envenomation-induced acute thrombotic inferior myocardial infarction
by: Ahmet Oytun Baykan, et al.
Published: (2016-02-01)

COMPUTER FORECASTING AND EXPERIMENTAL VALIDATION OF ANTIAGGREGATE PROPERTIES OF CETRINE, GLURENORM, MOEX AND DILTHIAZEM
by: Nikolay P. Votintsev
Published: (2018-07-01)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01)

Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
by: Ze-Mu Wang, et al.
Published: (2023-10-01)

Diffuse alveolar hemorrhage; An under-diagnosed and rare complication of glycoprotein IIb/IIIa inhibitors
by: Hamidreza Hekmat, et al.
Published: (2022-09-01)

Management of immediate partial bioresorbable vascular scaffold stent thrombosis
by: Ziad Said Dahdouh, et al.
Published: (2017-03-01)

Glanzmann thrombasthenia associated with human immunodeficiency virus-positive patient
by: Rakesh Kumar Manne, et al.
Published: (2014-01-01)

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
by: Salam Amar M, et al.
Published: (2001-07-01)

Pseudotrombocitopenia Pseudothrombocytopenia
by: Luci Maria Sant'Ana Dusse, et al.
Published: (2004-10-01)

Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis
by: JongSung Hahn, et al.
Published: (2023-07-01)

Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?
by: Dimitrios Alexopoulos, et al.
Published: (2018-04-01)

A rare case of eptifibatide-induced thrombocytopenia
by: Khalil Kamar, et al.
Published: (2021-03-01)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
by: Zhe Wang, et al.
Published: (2020-03-01)

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial
by: Wonjae Lee, et al.
Published: (2018-10-01)

Assessment of Fibrinogen Macromolecules Interaction with Red Blood Cells Membrane by Means of Laser Aggregometry, Flow Cytometry, and Optical Tweezers Combined with Microfluidics
by: Alexey N. Semenov, et al.
Published: (2020-10-01)

Factors influencing platelet aggregation in patients with acute coronary syndrome
by: A V Mazurov, et al.
Published: (2014-09-01)

Implications of troponin testing in clinical medicine
by: Meinertz Thomas, et al.
Published: (2001-04-01)

Knowledge on Alzheimer's Disease among Public Hospitals and Health Clinics Pharmacists in the State of Selangor, Malaysia
by: Thimarul Huda Mat Nuri, et al.
Published: (2017-10-01)

Activation‐induced changes in platelet surface receptor expression and the contribution of the large‐platelet subpopulation to activation
by: Masaaki Moroi, et al.
Published: (2020-02-01)

Effect of transdermal hormone therapy on platelet haemostasis in menopausal women
by: Grzegorz Stachowiak, et al.
Published: (2015-02-01)

Effect of transdermal hormone therapy on platelet haemostasis in menopausal women
by: Grzegorz Stachowiak, et al.
Published: (2015-02-01)

Comparison between the effect of intracoronary bolus of tirofiban versus eptifibatide as adjunctive antiplatelet therapy on the outcome of primary coronary intervention in patients with acute anterior ST segment elevation myocardial infarction
by: Tarek M. Zaki, et al.
Published: (2011-06-01)

One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock
by: Krzysztof Myrda, et al.
Published: (2021-10-01)

Mind the Gap: Platelet Inhibition in Low‐Risk Acute Coronary Syndrome Undergoing Percutaneous Revascularization
by: Ravi K. Sharma, et al.
Published: (2019-12-01)

A phase 1, first-in-human study of 18F-GP1 positron emission tomography for imaging acute arterial thrombosis
by: Sun Young Chae, et al.
Published: (2019-01-01)

Gli antagonisti del recettore GPIIb/IIIa: farmacologia, clinica ed economia nelle sindromi coronariche acute NSTEMI e nelle rivascolarizzazioni per via percutanea
by: Lorenzo Pradelli
Published: (2005-12-01)

Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice
by: Gašper Tonin, et al.
Published: (2023-03-01)

Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood
by: Anne Landsem, et al.
Published: (2022-12-01)

Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
by: Dong Huang, et al.
Published: (2021-08-01)

Inibidores da glicoproteína IIb/IIIa na prática clínica Inhibidores de la glicoproteína IIb/IIIa en la práctica clínica Glycoprotein IIb/IIIa inhibitors in clinical practice
by: Felipe Maia, et al.
Published: (2009-01-01)